?重組SARS-CoV-2 (2019-nCoV) 3C-like Proteinase蛋白
| 英文名稱 | Recombinant SARS-Cov-2 3C-like Proteinase, His |
| 中文名稱 | 重組SARS-CoV-2 (2019-nCoV) 3C-like Proteinase蛋白 |
| 別????名 | M Proteinase; 3CL Proteinase; Recombinant SARS-Cov-2 3C-like Proteinase, His ??新冠病毒3CL蛋白酶; 新冠3CL蛋白酶; SARS-CoV-2 3CL蛋白酶; |
| 理論分子量 | 33.8kDa |
| 檢測分子量 | 33 kDa |
| 性????狀 | Lyophilized or Liquid |
| 濃????度 | >0.5 mg/ml |
| 物????種 | SARS-Cov-2 |
| 序????列 | 3264-3569/7096 |
| 純????度 | >95% as determined by SDS-PAGE |
| 純化方法 | AC |
| 內毒素 | Not analyzed |
| 表達系統 | E.coli |
| 活性 | Not tested |
| 標簽 | His |
| 緩?沖?液 | 20 mM Tris-HCl with 0.03% Proclin300 and 20% Glycerol. |
| 保存條件 | Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles. |
| 注意事項 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 產品介紹 | The viral main proteinase (M pro , also called 3CL pro ), which controls the activities of the coronavirus replication complex. It functions as a cysteine protease engaging in the proteolytic cleavage of the viral precursor polyprotein to a series of functional proteins required for coronavirus replication and is considered as an appealing target for designing anti-SARS agents. ? |
| 產品圖片 |

